|
diabetes
 9/9/2010 CHMP Meets To Discuss Avandia And Pandemrix, Europe
The Committee for Medicinal Products for Human Use (CHMP) met on Wednesday 8 September to discuss the ongoing benefit-risk review of the rosiglitazone-containing medicines Avandia, Avandamet and Avaglim...
9/9/2010 Insulin Implicated In Cell Survival, Cell Metabolism And Stress Response
Researchers at the Buck Institute for Age Research have discovered a novel way in which insulin affects cell metabolism and cell survival. Surprisingly the insulin signaling pathway, which is involved in aging, diabetes and stress response, is active at a deeper level of cell activity than scientists expected. The study appears in the September 8th issue of Cell Metabolism...
9/9/2010 Risk Of Gestational Diabetes, Cesarean Section, Reduced In The Obese By Bariatric Operations
Obese women who have bariatric surgical procedures before pregnancy were three times less likely to develop gestational diabetes (GDM) than women who have bariatric operations after delivery, according to new research findings published in the August issue of the Journal of the American College of Surgeons...
9/9/2010 Survey Data Reveals Shocking 'Insulin Pump Postcode Lottery'
A comprehensive new survey of all 152 PCTs undertaken and published by the Medical Technology Group (MTG), backed by national diabetes support groups INPUT, the Juvenile Diabetes Research Foundation (JDRF), clinicians and leading cross-party MPs, has exposed major inequities in care for patients with diabetes across the country...
9/9/2010 AHRQ Releases New Spanish Language Guides For Patients
HHS' Agency for Healthcare Research and Quality today released a series of free evidence-based guides designed to help Spanish speakers understand and compare the risks, benefits and side effects of treatments for eight health conditions. The guides provide valuable information that patients can use in talking with their clinicians...
9/9/2010 Short Sleepers At Higher Risk Of Type 2 Diabetes And Heart Disease
People who sleep less than six hours a night may be three times more likely to develop a condition which leads to diabetes and heart disease, according to researchers at the University of Warwick...
9/9/2010 Epitwin: Largest Ever Epigenetics Project Launched
One of the most ambitious large-scale projects in Human Genetics has been launched: Epitwin will capture the subtle epigenetic signatures that mark the differences between 5,000 twins on a scale and depth never before attempted, providing key therapeutic targets for the development of drug treatments...
9/9/2010 Concern About Rosiglitazone (Avandia) And How Drugs Are Regulated And Promoted, BMJ
There is serious concern about top-selling diabetes drug rosiglitazone (Avandia), its safety, as well as the whole system by which medications are regulated, evaluated and promoted worldwide, according to a BMJ (British Medical Journal) investigation. Dr. Fiona Godlee, BMJ Editor-in-Chief, thinks Avandia should not have been licensed; she believes it should be withdrawn...
9/9/2010 Vended Foods And Beverages May Be Linked To Obesity, Diabetes And Coronary Artery Disease
School children who consume foods purchased in vending machines are more likely to develop poor diet quality - and that may be associated with being overweight, obese or at risk for chronic health problems such as diabetes and coronary artery disease, according to research from the University of Michigan Medical School...
9/9/2010 Pediatric Weight Expert Provides Obesity Trinity Answers
In a first person paper published in the August 27, 2010 issue of Childhood Obesity, Dr. Melinda Sothern, Director of Health Promotion and Professor of Public Health at LSU Health Sciences Center New Orleans, provides three ways to de-program the 1950s obesity trinity underlying the current obesity epidemic in the United States and protect future generations from its health consequences...
9/9/2010 Why Fish Oils Work Swimmingly Against Diabetes
Researchers at the University of California, San Diego School of Medicine have identified the molecular mechanism that makes omega-3 fatty acids so effective in reducing chronic inflammation and insulin resistance. The discovery could lead to development of a simple dietary remedy for many of the more than 23 million Americans suffering from diabetes and other conditions...
9/9/2010 Halozyme Begins Phase 2 Clinical Trials With Insulin Analogs Lispro And Aspart With RHuPH20 In Type 1 And Type 2 Diabetes
Halozyme Therapeutics, Inc. (Nasdaq: HALO) announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLogŪ, and insulin lispro, the active ingredient in HumalogŪ...
9/9/2010 News From The Journal Of Clinical Investigation: Sept. 1, 2010
INFECTIOUS DISEASE: Modified adenovirus malaria vaccine works a treat in mice Malaria kills more than 1 million individuals each year. Despite intensive research, there is still no malaria vaccine approved for use. A team of researchers, led by Moriya Tsuji, at the Aaron Diamond AIDS Research Center, New York, has now designed a new vaccine that provides protection from malaria in mice...
9/9/2010 Diabetes 2 Drug Metformin May Protect Against Lung Cancer In Smokers
Two studies reveal that smokers may have a significantly lower risk of developing lung cancer and colorectal cancer with the drug metformin, which is commonly prescribed for diabetes type 2 treatment, the medical journal Cancer Prevention Research informs...
9/9/2010 More Patients Research Their Own Diseases, Seek To Manage Chronic Conditions
News outlets report on how the delivery of health care is being changed by empowered patients. USA Today: "In the past, most patients placed their entire trust in the hands of their physician. Your doc said you needed a certain medical test, you got it. Not so much anymore. Though some doctors find the newer 'empowered' patients taxing, others ...
9/9/2010 pSivida Announces Iluvien(R) Receives FDA Priority Review For Treatment Of Diabetic Macular Edema
pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, announced that its licensee, Alimera Sciences (NASDAQ:ALIM) has been notified that the U.S...
9/9/2010 New Study Singles Out Factors Linked To Cognitive Deficits In Type 2 Diabetes
Older adults with diabetes who have high blood pressure, walk slowly or lose their balance, or believe they're in bad health, are significantly more likely to have weaker memory and slower, more rigid cognitive processing than those without these problems, according to a new study published by the American Psychological Association...
9/9/2010 Experts Wonder Why Slimming Drug Meridia (sibutramine) Is Still On The Market In USA
Sibutramine, brand name Meridia is an appetite suppressant, a weight loss pill. Editors at the NEJM (New England Journal of Medicine) write it is difficult for them to discern a "credible rationale for keeping this medication on the market", even though it is restricted for people without heart disease...
9/9/2010 Growing Obesity, Diabetes Epidemics In California
A majority of adults in California are obese or overweight, and more than 2 million have been diagnosed with diabetes, according to a new study from the UCLA Center for Health Policy Research...
9/9/2010 Diabetic Macular Edema Drug Iluvien Gets FDA Priority Review
Iluvien(R) (fluocinolone acetonide intravitreal insert), an investigational sustained drug delivery system that releases sub-microgram levels of fluocinolone acetonide for DME (diabetic macular edema) treatment, has been accepted for filing and granted Priority Review States by the FDA (Food and Drug Administration, USA), Alimera Sciences, Inc. announced today...
9/9/2010 Many Older Adults With Diabetes Are Sexually Active But Have Problems
New research from the University of Chicago found that many middle-aged and older Americans with diabetes are sexually active but more likely to experience sexual problems compared with counterparts without diabetes...
9/9/2010 Genetic Variations Associated With Development Of End-Stage Kidney Disease In Chinese Patients With Diabetes
Examination of a gene involved in cell signaling finds that four common variants of this gene are associated with the development of end-stage renal disease in Chinese patients with type 2 diabetes, according to a study in the August 25 issue of JAMA. Renal (kidney) failure is an important cause of death among patients with type 2 diabetes...
9/9/2010 Wound Management Technologies Expands Distribution Foot Print In Florida With The Addition Of Central Medical Systems
Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) announced that its subsidiary Wound Care Innovations, LLC has further expanded its rapidly growing coverage of the Florida wound care market with the addition of Central Medical Systems to its already extensive list of distributors and suppliers...
9/9/2010 Gender Difference In Energy Compensation Effect Discovered By Researchers
The results of a new scientific study from Oxford Brookes University show that the consumption of caloric beverages has different affects on short-term total energy intake in men and women...
9/9/2010 Breastfeeding May Protect Mother From Developing Diabetes Type 2
A mother who breastfed her children has a considerably lower risk of developing Diabetes Type 2 when she is older, compared to a woman who had children but never breastfed, according to an article published in the American Journal of Medicine...
|
CanMedGlobal.com advantages
Save 50 to 90% off your local pharmacy
No Membership Fees
We Ship Internationally
Fast Service, Fast delivery time
|
|
|
|
|
